Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits: In vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent manner

Journal of Clinical Investigation

Volumn 97, Issue 8, 1996, Pages 1844-1851

  Brousseau, Margaret E ^a   Santamarina Fojo, Silvia ^a   Zech, Loren A ^a   Bérard, Annie M ^a   Vaisman, Boris L ^a   Meyn, Susan M ^a   Powell, Douglas ^a   Brewer Jr , H Bryan ^a   Hoeg, Jeffrey M ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Apolipoprotein A I; Cholesterol; High density lipoproteins; Lipoproteins; Metabolism

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; DOSE RESPONSE; ENZYME ACTIVITY; FAST PROTEIN LIQUID CHROMATOGRAPHY; GENE DOSAGE; GENE EXPRESSION REGULATION; HUMAN; HYPERLIPOPROTEINEMIA; NONHUMAN; PRIORITY JOURNAL; RABBIT; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANIMALS, NEWBORN; APOLIPOPROTEIN A-I; CHOLESTEROL ESTERS; CHOLESTEROL, HDL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GENE EXPRESSION; HUMANS; HYPERLIPOPROTEINEMIAS; KINETICS; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PHOSPHOLIPIDS; RABBITS;

EID: 0029935422     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118614     Document Type: Article

References (56)

1. Glomset, J.A., E T. Janssen, R. Kennedy, and J. Dobbins 1966. Role of plasma lecithin:cholesterol acyltransferase in the metabolism of high density lipoproteins. J. Lipid Res. 7:638-648
2. Glomset, J.A. 1968. The plasma lecithin:cholesterol acyltransferase reaction. J. Lipid Res. 9:155-167.
3. Albers, J.J., C.H Chen, and J.L. Adolphson. 1981. Lecithin:cholesterol acyttransferase (LCAT) mass; its relationship to LCAT activity and cholesterol esterification rate. J Lipid Res. 22:1206-1213.
4. Castro, G.R., and C.J. Fielding. 1988. Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. Biochemistry. 27: 25-29.
5. Fielding, P E., M. Kawano, A.L. Catapano, A. Zoppo, S. Marcovina, and C.J. Fielding. 1994. Unique epitope of apolipoprotein A-I expressed in pre-beta-1 high density lipoprotein and its role in the catalyzed efflux of cellular cholesterol Biochemistry. 33:6981-6985.
6. Tall, A.R. 1993. Plasma cholesteryl ester transfer protein. J. Lipid Res. 34:1255-1274.
7. Goldstein, J L., M.S. Brown, R.G. Anderson, D W. Russell, and W.J. Schneider. 1985. Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Anna Rev Cell Biol. 1:1-39.
8. Herz, J., U. Hamann, S. Rogne, O. Myklebost, H. Gausepohl, and K.K. Stanley. 1988 Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO (Eur. Mol. Biol. Organ.) J. 7:4119-4127.
9. Strickland, D.K., J.D. Ashcom, S. Williams, W.H. Burgess, M. Migliorini, and W S. Argraves 1990. Sequence identity between the alpha 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J. Biol. Chem 265:17401-17404.
10. Fielding. C.J. 1984. The origin and properties of free cholesterol potential gradients in plasma and their relation to atherogenesis. J Lipid Res 25: 1624-1628.
11. Fielding, C.J., V.G. Shore, and P.E. Fielding. 1972. A protein cofactor of lecithin:cholesterol acyltransferase Biochem Biophvs. Res. Commun. 46:1493-1498.
12. Jonas, A. 1991. Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteins. Biochim. Biophys. Acta 1084:205-220.
13. Schaefer, E.J., L.A. Zech, L.L. Jenkins, T.J. Bronzert, E A. Rubalcaba, R.T. Lindgren, R.L. Aamodt, and H.B. Brewer. Jr. 1982. Human apolipoprotein A-I and A-II metabolism. J. Lipid Res 23:850-862.
14. Brinton, E.A., S. Eisenberg, and J.L. Breslow. 1989. Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women. J. Clin. Invest. 84:262-269.
15. Brinton, E.A., S. Eisenberg, and J.L. Breslow. 1990. A tow-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates. J. Clin. Invest. 85:144-151
16. Brinton, E.A , S. Eisenberg, and J.L. Breslow. 1994. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size: effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution. Arterioscler. Thromb. 14:707-720.
17. Ikewaki, K., L A Zech, M. Kindt, H.B. Brewer, Jr., and D.J. Rader. 1995. Apolipoprotein A-II production is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-LA-II in normolipidemic humans. Arterioscler. Thromb Vasc. Biol. 15:306-312.
18. Melchior, G.W , C.K. Castle, T.J Vidmar, H.G. Polites, and K.R. Marotti. 1990. ApoA-I metabolism in cynomolgus monkeys: male-female differences. Biochim. Biophys. Acta. 1043:97-105.
19. Pape, M.E., E.F. Rehberg, K.R Marotti, and G.W. Melchior. 1991. Molecular cloning, sequence, and expression of cynomolgus monkey cholesteryl ester transfer protein. Inverse correlation between hepatic cholesteryl ester transfer protein mRNA levels and plasma high density lipoprotein levels. Arterioscler. Thromb. 11:1759-1771.
20. Rader, D.J., G. Castro, L.A. Zech, J.C. Fruchart, and H.B. Brewer, Jr. 1991. In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-II. J Lipid. Res. 32 1849-1859.
21. Brinton, E.A., S. Eisenberg, and J.L. Breslow. 1991. Increased apoA-I and apoA-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. J. Clin Invest. 87: 536-544.
22. Horowitz, B.S., I.J. Goldberg, J. Merab, T. Vanni, R. Ramakrishnan, and H.N. Ginsberg 1991. Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol. J. Clin. Invest 91:1743-1752.
23. Melchior, G.W , C.K. Castle, R.W. Murray, W.L. Blake, D.M. Dinh, and K.R. Marotti. 1994. Apolipoprotein A-I metabolism in cholesteryl ester transfer protein transgenic mice: insights into the mechanisms responsible for low plasma high density lipoprotein levels. J. Biol. Chem. 269:8044-8051
24. Glomset, J.A., G. Assmann, E. Gjone, and K.R. Norum 1995. Lecithin: cholesterol acyltransferase deficiency and fish eye disease. In The Metabolic and Molecular Bases of Inherited Disease. C.R. Scriver, A L Beaudet, W S. Sly, and D. Valle, editors. McGraw-Hill, Inc., New York 1933-1952
25. Forte, T., K.R. Norum, J.A. Glomset, and A.V. Nichols. 1971. Plasma lipoproteins in familial lecithin.cholesterol acyltransferase deficiency. structure of low and high density lipoproteins as revealed by electron microscopy. J. Clin Invest 50:1141-1148.
26. Forte, T.M , and L.A. Carlson. 1984. Electron microscopic structure of serum lipoproteins from patients with fish eye disease. Arteriosclerosis. 4:130-137.
27. Rader, D.J., K. Ikewaki, N Duverger, H. Schmidt, H. Pritchard, J. Frolich, M. Clerc, M.-F. Dumon, T. Fairwell, L. Zech, S. Santamarina-Fojo, and H.B. Brewer, Jr. 1994. Markedly accelerated catabolism of apolipoprotein A-II (apoA-II) and high density lipoproteins containing apoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease. J. Clin. Invest. 93: 321-330.
28. Gylling, H., and T.A. Miettinen. 1992. Noncholesterol sterols, absorption and synthesis of cholesterol and apolipoprotein A-I kinetics in a Finnish lecithin-cholesterol acyltransferase deficient family. Atherosclerosis 95 25-33
29. Vaisman, B.L., H -G. Klein, M. Rouis, A.M. Berard, M.R. Kindt, G.D. Talley, S.M. Meyn, R F. Hoyt, Jr., S.M. Marcovina, J.J. Albers, J.M. Hoeg, H B. Brewer, Jr., and S. Santamarina-Fojo. 1995 Overexpression of human lecithin cholesterol acyltransferase leads to hyper-alphalipoproteinemia in transgenic mice. J. Biol. Chem. 270:12269-12275.
30. Hoeg, J.M., B.L. Vaisman, S.J. Demosky, Jr., S.M. Meyn, G.D. Talley, R F. Hoyt, Jr., S. Feldman, A.M. Bérard, N Sakai, D. Wood, M.E Brousseau, S. Marcovina, H.B. Brewer, Jr., and S. Santamarina-Fojo. 1996. Lecithin: cholesterol acyltransferase overexpression generates hyperalpha-lipoproteinemia and a nonatherogenic lipoprotein pattern in transgenic rabbits. J Biol. Chem. 271.4396-4402.
31. Chapman, M.J. 1980 Animal lipoproteins: chemistry, structure, and comparative aspects. J. Lipid Res. 21:789-853.
32. Ha, Y.C., and P.J. Barter. 1982 Differences in plasma cholesteryl ester transfer activity in sixteen vertebrate species. Comp. Biochem. Physiol. [B] 71 265-269.
33. Clay, M.A., G.J. Hopkins, C.P. Ehnholm, and P.J. Barter. 1989. The rabbit as an animal model of hepatic lipase deficiency. Biochim Biophys. Acta. 1002:173-181
34. Borresen, A.L., T.J. Kindt, and K. Berg. 1978. Partial purification and characterization of the inherited HI 1 and R 67 antigens of rabbit serum high density lipoprotein. J. Immunogenet. 5:71-86.
35. 2+ precipitation procedure for quantitation of high density lipoprotein cholesterol. Clin. Chem 28:1379-1388.
36. Albers, J.J., J.L. Adolphson, and C.-H. Chen. 1981. Radioimmunoassay of human plasma lecithin-cholesterol acyltransferase. J. Clin. Invest. 67:141-148.
37. Klein, H.-G , P. Lohse, N. Duverger, J.J. Albers, D J. Rader, L.A. Zech, S. Santamarina-Fojo, and H.B. Brewer, Jr. 1993. Two different allelic mutations in the lecithin.cholesterol acyltransferase (LCAT) gene resulting in classic LCAT deficiency. LCAT (tyr83→top) and LCAT (tyr156→asn) J. Lipid Res. 34:49-58.
38. Stokke, K.T , and K.R. Norum. 1971 Determination of lecithin:cholesterol acyltransfer in human blood plasma. Scand J. Clin. Lab Invest. 27:21-27.
39. Jiao, S., T G Cole, R.T. Kitchens, B. Pfleger, and G. Schonfeld 1990. Genetic heterogeneity of lipoproteins in inbred strains of mice: analysis by gelpermeation chromatography. Metabolism 39:155-160.
40. Brewer, H.B., Jr., R Ronan, M. Meng, and C. Bishop. 1986. Isolation and characterization of apolipoproteins A-I, A-II, and A-IV In Methods in Enzymology. J.P Segrest and J Albers, editors. Academic Press, Orlando. 223-246.
41. Gregg, R.E., L.A Zech, E.J. Schaefer, and H.B. Brewer, Jr. 1984. Apolipoprolein E metabolism in normolipoproteinemic human subjects. J. Lipid Res 25:1167-1176.
42. Ikewaki, K., D J. Rader, T. Sakamoto, M. Nishiwaki, N. Wakimoto, J.R. Schaefer, T Ishikawa, T. Fairwell, L.A. Zech, H. Nakamura, M Nagano, and H.B. Brewer, Jr. 1993. Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency. J Clin Invest. 92:1650-1658
43. Terpstra, A.H.M . and A.E Pels 1988. Isolation of plasma lipoproteins by a combination of differential and density gradient ultracentrifugation. Fresenius Z Anal. Chem 330:149-151.
44. Shepherd, J, C.J. Packard, A.M. Gotto, and D.O. Taunton. 1978. A comparison of two methods to investigate the metabolism of human apolipoproteins A-I and A-II. J. Lipid Res 19:656-661.
45. Vega, G.L., H. Gylling, A.V. Nichols, and S.M. Grundy. 1991. Evaluation of a method for study of kinetics of autologous apolipoprotein A-I. J. Lipid Res. 32:867-875.
46. Ikewaki, K., D.J Rader, J.R. Schaefer, T. Fairwell, L.A. Zech, and H.B. Brewer, Jr. 1993. Evaluation of apoA-I kinetics in humans using simultaneous endogenous stable isotope and exogenous radiotracer methods. J. Lipid Res. 34:2207-2215.
47. Berman, M., and M. Weiss. 1978. SAAM Manual. National Institutes of Health, Bethesda, MD. DHEW Publication No. (NIH) 78:180.
48. Ross, A.C., and D.B. Zilversmit, 1977. Chylomicron remnant cholesteryl esters as the major constituent of very low density lipoproteins in plasma of cholesterol-fed rabbits. J. Lipid Res 18:169-181.
49. Liang, H -Q., K.-A. Rye, and P.J. Barter. 1994. Dissociation of lipid-free apolipoprotein A-I from high density lipoproteine. J. Lipid Res. 35:1187-1199.
50. Garber, D.W., Y V Venkatachalapathi, K.B. Gupta, J. Ibdah, M.C. Phillips, J.B. Hazelrig, J P. Segrest, and G.M. Anantharamaiah. 1992. Turnover of synthetic class A amphipathic peptide analogues of exchangeable apolipoproteins in rats. Correlation with physical properties Arterioscler. Thromb 12: 886-894.
51. Westerlund, J.A , and K.H. Weisgraber 1993. Discrete carboxyl-terminal segments of apolipoprotein E mediate lipoprotein association and protein oligomerization. J Biol. Chem. 268:15745-15750.
52. Hopkins, G.J., and P.J. Barter. 1986. Role of triglyceride-rich lipoproteins and hepatic lipase in determining the particle size and composition of high density lipoproteins. J. Lipid Res. 27:1265-1277
53. 2-like particle during lipolysis of very low density lipoproteins in vitro. Proc. Natl. Acad Sci. USA. 75:4519-4523.
54. Barter, P.J., G.J Hopkins, and L. Gorjatschko. 1985. Lipoprotein substrates for plasma cholesterol esterification. Influence of particle size and composition of the high density lipoprotein subfraction 3. Atherosclerosis. 58:97-107.
55. Sparks, D.L , G.M. Anantharamaiah, J.P. Segrest, and M.C. Phillips 1995 Effect of the cholesterol content of reconstituted LpA-I on lecithin:cholesterol acyltransferase activity J Biol. Chem 270:5151-5157.
56. Albers, J J., R.O. Bergelin, J.L. Adolphson. and P.W. Wahl. 1982. Population-based reference values for lecithin-cholesterol acyltransferase (LCAT). Atherosclerosis. 43:369-379.